Press Releases

NEW YORK, Sept. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 21, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective Date Index Name Action Company Name Ticker GICS Sector  Sept 21, 2026 S&P 100AdditionDell Techno

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced an update on Novartis’ Phase 3 results from the HORIZON outcomes trial for pelacarsen, an antisense oligonucleotide studied in patients with atherosclerotic cardiovascular (CV) disease and elevated lipoprotein(a), or Lp(a). The trial did not meet its primary endpoint of reducing the risk of cardiovascular events, a composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and urgent coronary revascularization requiring hospitalization in the overall study population, compared to placebo. Novartis intends to present the Lp(a) HORIZON trial data at an upcoming medical con

Approval based on SERENA-6 Phase III trial results which showed combination reduced the risk of disease progression or death by 56% in patients with an emergent ESR1 tumor mutation Innovative treatment strategy has potential to reshape 1st-line treatment paradigm for patients in this setting AstraZeneca’s ETCAMAH® (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, ba

GUADALAJARA, Mexico, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE:PAC, BMV:GAP) ("the Company" or "GAP") announces preliminary terminal passenger traffic figures for August 2026, compared with August 2025. During August 2026, the 12 Mexican airports operated by GAP recorded a 2.6% increase in total passenger traffic compared to August 2025. Guadalajara and Tijuana airports reported an increase of 10.5% and 1.2%, respectively, while Puerto Vallarta and Los Cabos airports reported a decrease of 10.3% and 6.2%, respectively, compared to August 2025. With respect to GAP’s airports in Jamaica, Kingston airport recorded an increase of 2.8%, while Mo

Portage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will now participate in a fireside chat session at 10:15 a.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and servic

Approval recommends repeat Guardant360 CDx testing every three months during therapy to detect emerging ESR1 mutations before clinical or radiographic disease progressionIn the Phase III SERENA-6 trial, ctDNA-guided treatment using Guardant360 CDx with camizestrant plus a CDK4/6 inhibitor following detection of an ESR1 mutation reduced the risk of disease progression or death by 56%Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) to identify patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer harbor

TORONTO and CHICAGO, Sept. 4, 2026 /CNW/ -- BMO Financial Group (TSX:BMO) (NYSE:BMO) today announced the completion of the sale of 138 branches to First-Citizens Bank & Trust Company ("First Citizens Bank"). As previously announced, the branches are in North Dakota, South Dakota, Wyoming, Nebraska, Kansas, Missouri, Oklahoma, and Idaho, as well as select branches in Minnesota, Oregon, and Illinois.The transaction supports BMO's strategy to optimize its U.S. financial center network and redeploy capital and resources to markets with strong client engagement and long-term growth potential.About BMO Financial Group BMO Financial Group is the eighth largest bank in North America by assets, with

New York, NY, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Alpha Compute Corp. (NASDAQ:ALP) ("Alpha Compute" or the "Company"), a technology company scaling global AI infrastructure and digital assets, today issued a comprehensive market update to its shareholders, highlighting its rapidly expanding cash flows, deep sales pipeline, and recent operational milestones achieved over the past 60 days. The executive leadership emphasizes that the Company faces no unannounced operational challenges or undisclosed material concerns. Fully focused on execution, Company management considers Alpha Compute significantly undervalued relative to its strong balance sheet assets, accelerating annual recurring cash

SANTA CLARITA, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- HII’s (NYSE:HII) executive vice president of maritime systems and corporate strategy, Eric Chewning, reaffirmed the company’s commitment to strengthening the nation’s defense industrial base and revitalizing U.S. shipbuilding today during a House Appropriations Subcommittee on Defense field hearing. Speaking at College of the Canyons before subcommittee Chairman Rep. Ken Calvert, and members of the subcommittee, Chewning underscored the critical importance of a modernized workforce, upgraded shipyard infrastructure, and an expanded maritime industrial base. "America’s ability to maintain peace and defend our interests depends on a

Seasoned CPG finance executive brings more than 25 years of experience across beverage, food, and premium pet food.Laird Superfood, Inc. (NYSE:LSF) today announced the appointment of Mark Johnson as Chief Financial Officer, effective October 1, 2026. Mr. Johnson will report to Chief Executive Officer Jason Vieth and will serve as the Company’s principal financial officer and principal accounting officer.Mr. Johnson brings more than 25 years of finance leadership across public consumer packaged goods and private equity-backed companies. He joins Laird Superfood from Tropicana Brands Group, where he served as Vice President of Finance – North America. Previously, he was Vice President – Commer

SINGAPORE, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE:POAS), ("Phaos" or "the Company"), an advanced microscopy solutions headquartered in Singapore, today announced the results of its extraordinary general meeting of shareholders (the "Extraordinary General Meeting"), which was held on August 31, 2026 at 9:30 p.m. Singapore Time (9:30 a.m. Eastern Time). A quorum of shareholders was present in person or by proxy, and the Extraordinary General Meeting was duly constituted. Each of the proposals set out in the Company’s notice of meeting and proxy statement dated August 12, 2026 was put to a vote and was duly approved by the requisite majority of s

NEW YORK, Sept. 4, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that Sandesh Seth, Chairman and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, being held September 14-16, 2026, in New York, NY. Company management will also be available for one-on-one meetings with investors. Conference DetailsEvent: H.C. Wainwright 28th Annual Global Investment ConferencePresentation Date and Time: Monday, September 14, 2026, 3:00 – 3:30 p.m. ETLocation: New York, NYRegist

WALTHAM, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE:CXT) ("Crane NXT" or the "Company"), a global leader in authentication and traceability technologies, today announced it will participate in the 2026 Jefferies Global Industrial Conference on Thursday, September 10, 2026. The conference will include a fireside chat with Aaron Saak, President and Chief Executive Officer and Christina Cristiano, Senior Vice President and Chief Financial Officer which will be held at 1:30p.m. Eastern Time. Participants may access the live webcast through the Investors section of Crane NXT’s website at www.cranenxt.com. An archived replay will be available on the company’s website after t

BEDMINSTER, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the "Company") (NYSE:MTNB) announced today that on August 31, 2026, it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide") requiring a company to have stockholders’ equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. As of June 30, 2026, the Company had stockholders’ equity of $1.8 million and has

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) partner Novartis today announced that the pelacarsen Phase 3 Lp(a)HORIZON study, a pioneering cardiovascular outcomes trial, did not meet its primary endpoint of reducing the risk of cardiovascular events, a composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and urgent coronary revascularization requiring hospitalization, compared to placebo. Consistent with previous studies, substantially lower lipoprotein (a) [Lp(a)] levels were achieved with pelacarsen. Elevated Lp(a) is an inherited cardiovascular risk factor affecting approximately one in five people worldwide with no approved targeted treatment. "Although p

Residential electric rates would remain the lowest among Maryland investor-owned utilitiesWILLIAMSPORT, Md., Sept. 4, 2026 /PRNewswire/ -- Potomac Edison, a subsidiary of FirstEnergy Corp. (NYSE:FE), is proposing a Maryland rate adjustment to support continued investment in the electric system, including upgrades to aging infrastructure, grid modernization and projects designed to strengthen reliability. The proposed $52.8 million rate adjustment would increase the monthly bill for the average residential customer by approximately 5.3%. Even with the proposed adjustment, Potomac Edison's residential rates would remain the lowes

BEIJING, Sept. 4, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ:CCG) ("Cheche", "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the six months ended June 30, 2026. Key Business HighlightsPartnerships with New Energy Vehicle (NEV) companies numbered 18 in the first half 2026 and led to 1,049,000 policies with corresponding written premium of RMB3.2 billion (US$472.0 million), representing an increase of 29.5% and 23.7%, respectively, compared to the prior-year period.Net revenues decreased 34.4% to RMB885.0 million (US$130.4 million) as we have been proactively restructuring business portfolio to focus on high-ma

IMPORTANT NOTICE – DISCLAIMER Not for release or distribution or publication in whole or in part, directly or indirectly, in or into Australia, Canada, Japan or the Republic of South Africa. These materials do not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan or the Republic of South Africa. The securities mentioned herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States or to U.S. persons absent such registration, except pursuant to an exemption from, or in a transaction

Master plan features four new communities affordably priced from the $300,000s and over 12 acres of planned on-site parks and trails.NORTH LAS VEGAS, Nev., Sept. 4, 2026 /PRNewswire/ -- KB Home (NYSE:KBH), one of the largest and most trusted homebuilders in the U.S., today announced the opening of the first phase of Sandstone, the homebuilder's massive new master plan in North Las Vegas. This master plan spans nearly 300 acres, with four new communities and over 1,500 new homes within the Villages at Tule Springs. Sandstone also offers over 12 acres of planned on-site parks, an extensive trail system and a new trailhead with access to the Tule Springs Fossil Beds National Monument.

HOUSTON, Texas, Sept. 04, 2026 (GLOBE NEWSWIRE) -- TOP Financial Group Limited (NASDAQ:TOP, "TOP" or the "Company")), a fast-growing online brokerage firm specializing in local and foreign equities, futures, and options products, today announced the strategic relocation of its global headquarters to the United States. This transition marks a pivotal milestone in the company’s long-term growth strategy, as it gradually shifts its primary corporate focus and operational footprint to the American market. The new headquarters address is: 4201 Main Street, Suite 200, Houston, Texas 77002. The phased relocation will take place over the coming months. It is designed to position TOP closer to it